BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
Language English Country United States Media print-electronic
Document type Journal Article
Grant support
PROGRES Q40/08
PROGRES Q40/08
grant no. 17-28539A
grant no. 17-28539A
MH CZ - DRO (UHHK, 00179906)
MH CZ - DRO (UHHK, 00179906)
PubMed
31073843
PubMed Central
PMC7090732
DOI
10.1007/s12223-019-00712-4
PII: 10.1007/s12223-019-00712-4
Knihovny.cz E-resources
- MeSH
- Aspergillus genetics isolation & purification pathogenicity MeSH
- Bronchoalveolar Lavage Fluid microbiology MeSH
- DNA, Fungal genetics MeSH
- Adult MeSH
- Galactose analogs & derivatives MeSH
- Hematologic Neoplasms complications microbiology MeSH
- Intensive Care Units MeSH
- Middle Aged MeSH
- Humans MeSH
- Mannans analysis MeSH
- Adolescent MeSH
- Young Adult MeSH
- Neutropenia microbiology MeSH
- Pneumocystis carinii genetics isolation & purification pathogenicity MeSH
- Pneumonia, Pneumocystis diagnosis microbiology MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Streptococcus pneumoniae genetics isolation & purification pathogenicity MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- DNA, Fungal MeSH
- galactomannan MeSH Browser
- Galactose MeSH
- Mannans MeSH
The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies over a period of 7 years. The results of culture methods, PCR, and immunoenzymatic sandwich microplate assays for Aspergillus galactomannan (GM) in BALF were analyzed. Further, the diagnostic thresholds for Aspergillus GM and Pneumocystis jiroveci were also calculated. Microbiological findings were present in 87% of BALF samples. Possible infectious pathogens were detected in 55% of cases; 32% were classified as colonizing. No significant difference in diagnostic yield or pathogen spectrum was found between non-neutropenic and neutropenic patients. There was one significant difference in BALF findings among intensive care units (ICU) versus non-ICU patients for Aspergillus spp. (22% versus 9%, p = 0.03). The most common pathogens were Aspergillus spp. (n = 86, 33% of BAL with causative pathogens) and Streptococcus pneumoniae (n = 46, 18%); polymicrobial etiology was documented in 20% of cases. A quantitative PCR value of > 1860 cp/mL for Pneumocystis jirovecii was set as a diagnostic threshold for pneumocystis pneumonia. The absorbance index of GM in BALF of 0.5 was set as a diagnostic threshold for aspergillosis. The examination of BAL fluid revealed the presence of pathogen in more than 50% of cases and is, therefore, highly useful in this regard when concerning pulmonary infiltrates.
See more in PubMed
Agusti C, Torres A (2009) Pulmonary infection in the immunocompromised patient: strategies for management. Wiley, Chichester
Azoulay E (2011) Pulmonary involvement in patients with hematological malignancies. Springer-Verlag, Berlin
Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, Raffoux E, Arnulf B, Socié G, Ribaud P, Tazi A. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest. 2010;137:410–415. doi: 10.1378/chest.09-0701. PubMed DOI
Bissinger AL, Einsele H, Hamprecht K, Schumacher U, Kandolf R, Loeffler J, Aepinus C, Bock T, Jahn G, Hebart H. Infectious pulmonary complications after stem cell transplantation or chemotherapy: diagnostic yield of bronchoalveolar lavage. Diagn Microbiol Infect Dis. 2005;52:275–280. doi: 10.1016/j.diagmicrobio.2005.03.005. PubMed DOI
Boeckh M. Complications, diagnosis, management, and prevention of CMV infections: current and future. ASH Educ Program Book. 2011;2011:305–309. doi: 10.1182/asheducation-2011.1.305. PubMed DOI
Boersma WG, Erjavec Z, van der Werf TS, de Vries-Hosper HG, Gouw ASH, Manson WL. Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL. Respir Med. 2007;101:317–325. doi: 10.1016/j.rmed.2006.04.021. PubMed DOI
Caira M, Mancinelli M, Leone G, et al. Invasive zygomycosis following hematopoietic stem cell transplantation. J Invasive Fungal Infect. 2010;4:47–53.
Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, Champlin RE, Aguilera EA, Tarrand JJ, Raad II. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006;85:278–287. doi: 10.1097/01.md.0000232560.22098.4e. PubMed DOI
Cordonnier C, Escudier E, Verra F, Brochard L, Bernaudin JF, Fleury-Feith J. Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern. Eur Respir J. 1994;7:114–120. doi: 10.1183/09031936.94.07010114. PubMed DOI
Cuenca-Estrella M, Bernal-Martinez L, Isla G, Gomez-Lopez A, Alcazar-Fuoli L, Buitrago MJ. Incidence of zygomycosis in transplant recipients. Clin Microbiol Infect. 2009;15:37–40. doi: 10.1111/j.1469-0691.2009.02978.x. PubMed DOI
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–1821. doi: 10.1086/588660. PubMed DOI PMC
Eriksson B-M, Dahl H, Wang F-Z, Elvin K, Hillerdal G, Lundholm M, Linde A, Olding-Stenkvist E. Diagnosis of pulmonary infections in immunocompromised patients by fiber-optic bronchoscopy with bronchoalveolar lavage and serology. Scand J Infect Dis. 1996;28:479–485. doi: 10.3109/00365549609037944. PubMed DOI
Falguera M, López A, Nogués A, Porcel JM, Rubio-Caballero M. Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest. 2002;122:2212–2216. doi: 10.1378/chest.122.6.2212. PubMed DOI
Gooskens J, Templeton KE, Claas EC, Templeton KE, Claas EC, van Bussel MJ, Smit VT, Kroes AC. Quantitative detection of herpes simplex virus DNA in the lower respiratory tract. J Med Virol. 2007;79:597–604. doi: 10.1002/jmv.20861. PubMed DOI
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr, Winthrop K. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. doi: 10.1164/rccm.200604-571ST. PubMed DOI
Hardak E, Avivi I, Berkun L, Raz-Pasteur A, Lavi N, Geffen Y, Yigla M, Oren I. Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome. Infection. 2016;44:491–497. doi: 10.1007/s15010-016-0873-3. PubMed DOI
Hohenadel IA, Kiworr M, Genitsariotis R, Zeidler D, Lorenz J. Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen. Thorax. 2001;56:115–120. doi: 10.1136/thorax.56.2.115. PubMed DOI PMC
Hummel M, Rudert S, Hof H, Hehlmann R, Buchheidt D. Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates. Ann Hematol. 2008;87:291–297. doi: 10.1007/s00277-007-0391-6. PubMed DOI
Joos L, Chhajed PN, Wallner J, Battegay M, Steiger J, Gratwohl A, Tamm M. Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respir Med. 2007;101:93–97. doi: 10.1016/j.rmed.2006.04.006. PubMed DOI
Khodavaisy S, Hedayati MT, Alialy M, et al. Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis. Curr Med Mycol. 2015;1:12–17. doi: 10.18869/acadpub.cmm.1.1.12. PubMed DOI PMC
Kim SW, Rhee CK, Kang HS, Lee HY, Kang JY, Kim SJ, Kim SC, Lee SY, Kim YK, Lee JW. Diagnostic value of bronchoscopy in patients with hematologic malignancy and pulmonary infiltrates. Ann Hematol. 2015;94:153–159. doi: 10.1007/s00277-014-2172-3. PubMed DOI
Kuehnhardt D, Hannemann M, Schmidt B, Heider U, Possinger K, Eucker J. Therapeutic implication of BAL in patients with neutropenia. Ann Hematol. 2009;88:1249–1256. doi: 10.1007/s00277-009-0747-1. PubMed DOI
Kumar D, Humar A, Plevneshi A, Green K, Prasad GVR, Siegal D, the Toronto Invasive Bacterial Diseases Networke. McGeer A. Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance. Am J Transplant. 2007;7:1209–1214. doi: 10.1111/j.1600-6143.2006.01705.x. PubMed DOI
Kumar D, Humar A, Plevneshi A, et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant. 2008;41:743–747. doi: 10.1038/sj.bmt.1705964. PubMed DOI
Linssen CFM, Jacobs JA, Stelma FF, van Mook WNKA, Terporten P, Vink C, Drent M, Bruggeman CA, Smismans A. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med. 2008;34:2202–2209. doi: 10.1007/s00134-008-1231-4. PubMed DOI
Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34:1094–1097. doi: 10.1086/339329. PubMed DOI
Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K, Heinen C, Crepin B, Eldere JV, Tabouret M, Donnelly JP, Verweij PE. Optimization of the cutoff value for the aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis. 2007;44:1329–1336. doi: 10.1086/514349. PubMed DOI
Malcolm E, Arruda E, Hayden FG, Kaiser L. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages. J Clin Virol. 2001;21:9–16. doi: 10.1016/S1386-6532(00)00180-3. PubMed DOI
Maschmeyer G, Carratalà J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, Lorenz J, Neumann S, Rieger C, Ruhnke M, Salwender H, Schmidt-Hieber M, Azoulay E, Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) Ann Oncol. 2015;26:21–33. doi: 10.1093/annonc/mdu192. PubMed DOI PMC
Mühlethaler K, Bögli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, Mühlemann K, Garzoni C. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J. 2012;39:971–978. doi: 10.1183/09031936.00095811. PubMed DOI
Murdoch DR, Anderson TP, Beynon KA, Chua A, Fleming AM, Laing RTR, Town GI, Mills GD, Chambers ST, Jennings LC. Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol. 2003;41:63–66. doi: 10.1128/JCM.41.1.63-66.2003. PubMed DOI PMC
Oren I, Hardak E, Zuckerman T, Geffen Y, Hoffman R, Yigla M, Avivi I. Does molecular analysis increase the efficacy of bronchoalveolar lavage in the diagnosis and management of respiratory infections in hemato-oncological patients? Int J Infect Dis. 2016;50:48–53. doi: 10.1016/j.ijid.2016.07.011. PubMed DOI
Parody R, Rabella N, Martino R, Otegui M, del Cuerpo M, Coll P, Sierra J. Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies. Am J Hematol. 2007;82:807–811. doi: 10.1002/ajh.20974. PubMed DOI
Rano A, Agusti C, Jimenez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax. 2001;56:379–387. doi: 10.1136/thorax.56.5.379. PubMed DOI PMC
Rolston KVI, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis. 2007;45:228–233. doi: 10.1086/518873. PubMed DOI
Siwek GT, Dodgson KJ, de Margarida M-S, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis. 2004;39:584–587. doi: 10.1086/422723. PubMed DOI
Smith MD, Derrington P, Evans R, Creek M, Morris R, Dance DAB, Cartwright K. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol. 2003;41:2810–2813. doi: 10.1128/JCM.41.7.2810-2813.2003. PubMed DOI PMC
Stelzmueller I, Lass-Floerl C, Geltner C, Graziadei I, Schneeberger S, Antretter H, Mueller L, Zelger B, Singh N, Pruett TL, Margreiter R, Bonatti H. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int. 2008;21:534–546. doi: 10.1111/j.1432-2277.2008.00657.x. PubMed DOI
Strålin K, Korsgaard J, Olcén P. Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. Eur Respir J. 2006;28:568–575. doi: 10.1183/09031936.06.00006106. PubMed DOI
Tan Susanna K., Burgener Elizabeth B., Waggoner Jesse J., Gajurel Kiran, Gonzalez Sarah, Chen Sharon F., Pinsky Benjamin A. Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis. Open Forum Infectious Diseases. 2015;3(1):ofv212. doi: 10.1093/ofid/ofv212. PubMed DOI PMC
Tang Fei-Fei, Zhao Xiao-Su, Xu Lan-Ping, Zhang Xiao-Hui, Chen Yu-Hong, Mo Xiao-Dong, Liu Kai-Yan, Huang Xiao-Jun. Utility of flexible bronchoscopy with polymerase chain reaction in the diagnosis and management of pulmonary infiltrates in allogeneic HSCT patients. Clinical Transplantation. 2017;32(1):e13146. doi: 10.1111/ctr.13146. PubMed DOI PMC
Torda A, Chong Q, Lee A, Chen S, Dodds A, Greenwood M, Larsen S, Gilroy N. Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2014;16:751–759. doi: 10.1111/tid.12268. PubMed DOI
Wieruszewski PM, Herasevich S, Gajic O, Yadav H. Respiratory failure in the hematopoietic stem cell transplant recipient. World J Crit Care Med. 2018;7:62–72. doi: 10.5492/wjccm.v7.i5.62. PubMed DOI PMC
Yu VL, Chiou CCC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MBF, Andremont A, Klugman KP, International Pneumococcal Study Group An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003;37:230–237. doi: 10.1086/377534. PubMed DOI
Zarrinfar H, Makimura K, Satoh K, Khodadadi H, Mirhendi H. Incidence of pulmonary aspergillosis and correlation of conventional diagnostic methods with nested PCR and real-time PCR assay using BAL fluid in intensive care unit patients. J Clin Lab Anal. 2013;27:181–185. doi: 10.1002/jcla.21580. PubMed DOI PMC